(Q50349915)

English

Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.

scientific article published on 9 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients. (English)

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

19

object named as

Linda T Vahdat

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

18

object named as

Shahin Rafii

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

7

object named as

Tessa Cigler

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

author name string

Sarika Jain

1

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Maureen M Ward

2

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Jennifer O'Loughlin

3

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Marissa Boeck

4

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Naomi Wiener

5

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Ellen Chuang

6

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Anne Moore

8

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Diana Donovan

9

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Christina Lam

10

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Marta V Cobham

11

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Sarah Schneider

12

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Paul Christos

13

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Rebecca N Baergen

14

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Alexander Swistel

15

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Maureen E Lane

16

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Vivek Mittal

17

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

language of work or name

0 references

publication date

9 December 2011

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

132

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

1

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

235-242

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

https://scigraph.springernature.com/pub.10.1007/s10549-011-1906-3

0 references

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Translating preclinical findings of (endothelial) progenitor cell mobilization into the clinic; from bedside to bench and back

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Vascular endothelial growth factor receptor 1 expression in pelvic lymph nodes predicts the risk of cancer progression after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Molecular basis of metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Gene expression profiling of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Angiogenesis in cancer and other diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Molecular portraits of human breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Tumor angiogenesis: therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

22 May 2018

Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

14 August 2018

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

14 August 2018

Endothelial progenitor cells in breast cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

14 August 2018

Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

14 August 2018

Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

14 August 2018

Erythropoietin regulates endothelial progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830135

14 August 2018

Circulating CD34+, CD133+, and Vascular Endothelial Growth Factor Receptor 2–Positive Endothelial Progenitor Cells in Myelofibrosis With Myeloid Metaplasia

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1906-3

21 January 2018

Residual risk of breast cancer recurrence 5 years after adjuvant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10549-011-1906-3

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 March 2018

http://europepmc.org/abstract/PMC/5830135

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50349915&oldid=2105109073"